The role of positron emission tomography in radiation treatment planning

Seminars in Nuclear Medicine

Volumn 34, Issue 4, 2004, Pages 293-299

  Bujenovic, Steven ^a,b  

^a Landstuhl Regional Medical Center   (United States)

^b Nuclear Medicine Associates

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE DERIVATIVE; BENZODIAZEPINE; CODEINE; DIAZEPAM; GLYCOPYRRONIUM BROMIDE; IBRITUMOMAB TIUXETAN; NARCOTIC AGENT; TOSITUMOMAB I 131;

ACCURACY; CANCER STAGING; ESOPHAGUS CARCINOMA; HUMAN; INFLAMMATION; LUNG CARCINOMA; LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; RADIATION FIELD; RADIOTHERAPY; RECTUM CARCINOMA; RECURRENT DISEASE; REVIEW; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 5444255710     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2004.06.005     Document Type: Article

References (53)

1. Schmidt DT, Eyrich GK, Graetz KW, et al. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Society of nuclear medicine 50th annual meeting, New Orleans, LA, 2003 (abstract)
2. Bujenovic L: FDG-PET in patients with head and neck carcinoma: Incidence of distant metastases in patients and the clinical impact on radiation planning. Society nuclear medicine 50th annual meeting, New Orleans, LA, 2003 (abstract)
3. L. Boucher, S. Rodrigue, R. Lecomte Respiratory gating for 3-dimensional PET of the thorax Feasibility and initial results J Nuc Med 45 2004 214 219
4. R. De Juan, B. Seifert, T. Berthold Clinical evaluation of a breathing protocol for PET/CT Eur Radiol 14 2004 1118-1112
5. G. Goerres, T. Hany, K. Ehab Head and neck imaging with PET and PET/CT Artefacts from dental metallic implants Eur J Nuc Med Mol Imaging 29 2002 367 370
6. L. Bujenovic, F. Mannting, R. Chakrabarti Artifactual 2-deoxy-2-[(18)F]fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner, using CT-based attenuation correction Mol Imaging Biol 5 2003 20 22
7. C. Cohade, R. Wahl Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography--clinical use, interpretation methods, diagnostic improvements Semin Nucl Med 33 2003 228 237
8. G. Antoch, L. Freudenberg, T. Beyer To enhance or not to enhance? F18-FDG and CT contrast agents in dual modality, F-18 FDG PET/CT J Nucl Med 45 suppl 1 2004 56S 65S
9. ICRU report; 62. prescribing, recording and reporting photon beam therapy: (Suppl to ICRU report 50), 1999
10. P. Rubin Clinical Oncology (ed 8) 2001 Saunders Philadelphia, PA
11. N. Saijo Progress in treatment of small-cell lung cancer Role of CPT-11 Br J Cancer 89 2003 2178 2183
12. W. Eberhardt, K. Albain, H. Pass Induction treatment before surgery for non-small cell lung cancer Lung Cancer 12 suppl 1 2003 59
13. C. Pottgen, W. Eberhardt, M. Stuschke Prophylactic cranial irradiation in lung cancer Curr Treat Options Oncol 5 2004 43 50
14. P. Rigo, R. Hustinx, T. Bury PET imaging in lung cancer P.E. Valk D.L. Bailey D.W. Townsend M.N. Maisey Positron Emission and Tomography Basic Science and Clinical Practice 2003 Springer London, UK 517 534
15. N.C. Gupta, T.J. Wuel, G.C. Graeber Mediastinal lymph node sampling following positron emission tomography with fluorodeoxy-glucose imaging in lung cancer staging Chest 120 2001 521 527
16. J.F. Vansteenkiste, S.G. Stroobants, P.R. DeLeyn Lymph node staging in non-small cell lung cancer with FDG-PET A prospective study on 690 lymph node stations from 68 patients J Clin Oncol 16 1998 2142 2149
17. R. Pieterman, J. van Putten, J. Meuzlaar Preoperative staging of non-small cell lung cancer with positron emission tomography N Engl J Med 343 2000 254 261
18. H. Steinert, M. Hauser, F. Allemann Non-small cell lung cancer Nodal staging with FDG PET versus CT with correlative lymph node mapping in sampling Radiology 202 1997 441 446
19. M. Yun, W. Kim, N. Alnafisi 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI J Nucl Med 42 2001 1795 1799
20. P. Valk, T. Pounds, D. Hopkins Staging nonsmall cell lung cancer by whole body positron emission tomography imaging Ann Thoracic Surg 60 1995 1573 1582
21. V. Kalff, R.J. Hicks, M.P. MacManus Clinical impact of (18)F fluoro-deoxyglucose positron emission tomography in patients with non-small-cell lung cancer A prospective study J Clin Oncol 19 2001 111 118
22. R.J. Hicks, V. Kalff, M.P. MacManus (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small-cell lung cancer J Nucl Med 42 2001 1596 1604
23. B. Mesurolle, F. Mignon, P. Meingan Head and neck cancer patients with pulmonary nodules value and role of CT-guided transthoracic needle aspiration biopsies Head Neck 25 2003 889 894
24. J. Erasums, E. Patz Jr Positron emission tomography imaging in the thorax Clin Chest Med 20 1999 715 724
25. 0) Surgery or irradiation? Head Neck 26 2004 127 135
26. D. Sessions, J. Lenox, G. Specter Analysis of treatment results for base of tongue cancer Laryngoscope 113 2003 1252 1261
27. W. Wong, M. Saunders The impact of FDG PET on the management of occult primary head and neck tumors Clin Oncol 15 2003 461 466
28. T. Stuckensen, A. Kovacs, S. Adams Staging of the neck in patients with oral cavity squamous cell carcinomas a prospective comparison of PET, ultrasound, CT and MRI J Craniomaxillofac Surg 28 2000 319 324
29. S. Stoeckli, M. Steinert, M. Pfaltz Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinomas? Head Neck 24 2002 345 349
30. S. Rege, A.A. Safa, L. Chaiken Positron emission tomography an independent indicator of radiocurability in head and neck carcinomas Am J Clin Oncol 23 2000 164 169
31. M. Lonneux, G. Lawson, C. Ide Positron emission tomography with fluoro- deoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient Laryngoscope 110 2000 1493 1497
32. V.J. Lowe, F.R. Dunphy, M. Varvares Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography Nead Neck 19 1997 666 674
33. 18F-FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms J Nucl Med 40 1999 1132 1137
34. J. Yahalom Changing role and decreasing size current trends in radiotherapy for Hodgkin's disease Curr Oncol Rep 4 2002 415 423
35. Yahalom J, Mauch P: The involved field is back: issues in delineating the radiation field in Hodgkin's disease. Ann Oncol Supplement 1:79-83
36. K. Strumpe, M. Urbinelli, H. Steinert Whole body positron emission tomography using fluorodeoxyglucose for staging lymphoma Effectiveness and comparison with computed tomography Eur J Nucl Med 25 1998 721 728
37. W.C. Lavely, D. Delbeke, J.P. Greer FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy Int J Radiat Oncol Biol Phys 57 2003 307 315
38. B.D. Minsky Adjuvant therapy for rectal cancer-the transatlantic view Colorectal Dis 5 2003 416 422
39. L.A. Kachnic, H.A. Shih, C.G. Willett Advances in combined radiation therapy for the management of rectal cancer Expert Rev Anticancer Ther 3 2003 471 483
40. C.G. Moertel, T.R. Fleming, J.S. Macdonald An evaluation of the carcino-embryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 270 1993 943 947
41. R. Huebner, K.C. Park, J. Shepard Meta-analysis of the literature for whole body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 2000 1177 1189
42. E. Vrdoljak, W. Hamm Current state-of-the-art of concomitant chemoradiation in cervical carcinomas Eur J Gynaecol Oncol 24 2003 475 479
43. M. Hockel Surgical treatment of locally advanced and recurrent cervical carcinoma Overview on current standard and new developments Onkologie 26 2003 452 455
44. S.E. Waggoner Cervical cancer Lancet 361 2003 2217 2225
45. K. Narayan, R.J. Hicks, T. Jobling A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer Potential impact on treatment Int J Gynecol Cancer 11 2001 263 271
46. P.W. Grigsby, B.A. Siegel, F. Dehdashti Posttherapy surveillance monitoring of cervical cancer by FDG-PET Int J Radiat Oncol Biol Phys 55 2003 907 913
47. R. Wahl Principals and practice of positron emission tomography 2002 Lippincott Philadelphia, PA
48. F. Flanagan, F. Dehdashi, B. Siegel Staging of esophageal cancer with 18F- fluorodeoxyglucose positron emission tomography Am J Roentgenol 168 1997 417 424
49. P. Flamen, A. Lerut, E. VanCutsen The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J Thorac Cardiovasc Surg 120 2000 1085 1092
50. T. Haney, H. Steinert, G. Goerres PET diagnostic accuracy: Improvement with in-line PET/CT system: Initial results Radiology 225 2002 575 581
51. J. Dearling, A. Flynn, J. Sutcliffe-Goulden Analysis of the regional uptake of radiolabeled deoxyglucose analogues in human tumor xenographs J Nucl Med 45 2004 101 107
52. Manoharan R, Ishihara Y, Bujenovic L: Rapid validation of PET/CT data sets for radiation treatment planning (RTP). Society of Nuclear Medicine 51st annual meeting, Philadelphia, PA, 2004 (abstract)
53. Zabic S, Bujenovic L: A computer algorithm for gross tumor volume determination in PET/CT images for radiation treatment planning. Society of Nuclear Medicine 51st annual meeting, Philadelphia, PA, 2004 (abstract)